Reliability of perfluoroalkyl substances in plasma of 100 women in two consecutive pregnancies

Environmental Research

Volumn 140, Issue , 2015, Pages 421-429

  Papadopoulou, Eleni ^a   Haug, Line S ^a   Sabaredzovic, Azemira ^a   Eggesbø, Merete ^a   Longnecker, Matthew P ^b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Correlations; MoBa; Perfluoroalkyl substances; PFOS; Pregnancy

Indexed keywords

ALKYL GROUP; DECANOIC ACID DERIVATIVE; PERFLEXANE; PERFLUOROALKYL SUBSTANCE; PERFLUORODECANOATE; PERFLUOROHEXANE SULFONATE; PERFLUORONONANOIC ACID; PERFLUOROOCTANESULFONIC ACID; PERFLUOROUNDECANOATE; UNCLASSIFIED DRUG; FLUOROCARBON;

BLOOD; BREASTFEEDING; COHORT ANALYSIS; CONCENTRATION (COMPOSITION); POLLUTION EXPOSURE; PREGNANCY; RELIABILITY ANALYSIS; SULFONATE; SURFACTANT; TOXICITY; WOMENS HEALTH;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BREAST FEEDING; COHORT ANALYSIS; EDUCATIONAL STATUS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL OBESITY; MATERNAL PLASMA; NORWAY; NORWEGIAN (CITIZEN); PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; QUALITY CONTROL; STATISTICAL ANALYSIS; TANDEM MASS SPECTROMETRY; BLOOD; REPRODUCIBILITY;

NORWAY;

ADULT; COHORT STUDIES; FEMALE; FLUOROCARBONS; HUMANS; NORWAY; PREGNANCY; REPRODUCIBILITY OF RESULTS;

EID: 84930948607     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2015.04.022     Document Type: Article

References (59)

1. Analytical Methods C. Measurement of near zero concentration: recording and reporting results that fall close to or below the detection limit. The Analyst 2001, 126:256-259.
2. Barry V., Winquist A., Steenland K. Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environ. Health Perspect. 2013, 121:1313-1318.
3. Beesoon S., Webster G.M., Shoeib M., Harner T., Benskin J.P., Martin J.W. Isomer profiles of perfluorochemicals in matched maternal, cord, and house dust samples: manufacturing sources and transplacental transfer. Environ. Health Perspect. 2011, 119:1659-1664.
4. Berg V., Nost T.H., Huber S., Rylander C., Hansen S., Veyhe A.S., Fuskevag O.M., Odland J.O., Sandanger T.M. Maternal serum concentrations of per- and polyfluoroalkyl substances and their predictors in years with reduced production and use. Environ. Int. 2014, 69:58-66.
5. Bland J.M., Altman D.G. Measurement error and correlation coefficients. Br. Med. J. 1996, 313:41-42.
6. Bosma R.J., van der Heide J.J., Oosterop E.J., de Jong P.E., Navis G. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int. 2004, 65:259-265.
7. Brantsaeter A.L., Whitworth K.W., Ydersbond T.A., Haug L.S., Haugen M., Knutsen H.K., Thomsen C., Meltzer H.M., Becher G., Sabaredzovic A., Hoppin J.A., Eggesbo M., Longnecker M.P. Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women. Environ. Int. 2013, 54:74-84.
8. Buck R.C., Franklin J., Berger U., Conder J.M., Cousins I.T., de Voogt P., Jensen A.A., Kannan K., Mabury S.A., van Leeuwen S.P. Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integr. Environ. Assess. Manag. 2011, 7:513-541.
9. Calafat A.M., Wong L.Y., Kuklenyik Z., Reidy J.A., Needham L.L. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ. Health Perspect. 2007, 115:1596-1602.
10. Domingo J.L., Ericson-Jogsten I., Perello G., Nadal M., Van Bavel B., Karrman A. Human exposure to perfluorinated compounds in Catalonia, Spain: contribution of drinking water and fish and shellfish. J. Agric. Food Chem. 2012, 60:4408-4415.
11. Ehresman D.J., Froehlich J.W., Olsen G.W., Chang S.C., Butenhoff J.L. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environ. Res. 2007, 103:176-184.
12. Eriksen K.T., Sorensen M., McLaughlin J.K., Tjonneland A., Overvad K., Raaschou-Nielsen O. Determinants of plasma PFOA and PFOS levels among 652 Danish men. Environ. Sci. Technol. 2011, 45:8137-8143.
13. Fabrega F., Kumar V., Schuhmacher M., Domingo J.L., Nadal M. PBPK modeling for PFOS and PFOA: validation with human experimental data. Toxicol. Lett. 2014, 230:244-251.
14. Fei C., McLaughlin J.K., Tarone R.E., Olsen J. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ. Health Perspect. 2007, 115:1677-1682.
15. Fromel T., Knepper T.P. Biodegradation of fluorinated alkyl substances. Rev. Environ. Contam. Toxicol. 2010, 208:161-177.
16. Fromme H., Mosch C., Morovitz M., Alba-Alejandre I., Boehmer S., Kiranoglu M., Faber F., Hannibal I., Genzel-Boroviczeny O., Koletzko B., Volkel W. Pre- and postnatal exposure to perfluorinated compounds (PFCs). Environ. Sci. Technol. 2010, 44:7123-7129.
17. Fromme H., Tittlemier S.A., Volkel W., Wilhelm M., Twardella D. Perfluorinated compounds - exposure assessment for the general population in Western countries. Int. J. Hyg. Environ. Health 2009, 212:239-270.
18. Geiger S.D., Xiao J., Ducatman A., Frisbee S., Innes K., Shankar A. The association between PFOA, PFOS and serum lipid levels in adolescents. Chemosphere 2014, 98:78-83.
19. Glynn A., Berger U., Bignert A., Ullah S., Aune M., Lignell S., Darnerud P.O. Perfluorinated alkyl acids in blood serum from primiparous women in Sweden: serial sampling during pregnancy and nursing, and temporal trends 1996-2010. Environ. Sci. Technol. 2012, 46:9071-9079.
20. Gutzkow K.B., Haug L.S., Thomsen C., Sabaredzovic A., Becher G., Brunborg G. Placental transfer of perfluorinated compounds is selective - a Norwegian Mother and Child sub-cohort study. Int. J. Hyg. Environ. Health 2012, 215:216-219.
21. Hanssen L., Dudarev A.A., Huber S., Odland J.O., Nieboer E., Sandanger T.M. Partition of perfluoroalkyl substances (PFASs) in whole blood and plasma, assessed in maternal and umbilical cord samples from inhabitants of arctic Russia and Uzbekistan. Sci. Total Environ. 2013, 447:430-437.
22. Halldorsson T.I., Fei C., Olsen J., Lipworth L., McLaughlin J.K., Olsen S.F. Dietary predictors of perfluorinated chemicals: a study from the Danish National Birth Cohort. Environ. Sci. Technol. 2008, 42:8971-8977.
23. Haug L.S., Huber S., Becher G., Thomsen C. Characterisation of human exposure pathways to perfluorinated compounds - comparing exposure estimates with biomarkers of exposure. Environ. Int. 2011, 37:687-693.
24. Haug L.S., Thomsen C., Brantsaeter A.L., Kvalem H.E., Haugen M., Becher G., Alexander J., Meltzer H.M., Knutsen H.K. Diet and particularly seafood are major sources of perfluorinated compounds in humans. Environ. Int. 2010, 36:772-778.
25. Haug L.S., Thomsen C., Becher G. A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring. J. Chromatogr. A 2009, 1216:385-393.
26. Haug L.S., Thomsen C., Becher G. Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples. Environ. Sci. Technol. 2009, 43:2131-2136.
27. Holzer J., Midasch O., Rauchfuss K., Kraft M., Reupert R., Angerer J., Kleeschulte P., Marschall N., Wilhelm M. Biomonitoring of perfluorinated compounds in children and adults exposed to perfluorooctanoate-contaminated drinking water. Environ. Health Perspect. 2008, 116:651-657.
28. Jain R.B. Effect of pregnancy on the levels of selected perfluoroalkyl compounds for females aged 17-39 years: data from National Health and Nutrition Examination Survey 2003-2008. J. Toxicol. Environ. Health Part A 2013, 76:409-421.
29. Javins B., Hobbs G., Ducatman A.M., Pilkerton C., Tacker D., Knox S.S. Circulating maternal perfluoroalkyl substances during pregnancy in the C8 Health Study. Environ. Sci. Technol. 2013, 47:1606-1613.
30. Ji K., Kim S., Kho Y., Sakong J., Paek D., Choi K. Major perfluoroalkyl acid (PFAA) concentrations and influence of food consumption among the general population of Daegu, Korea. Sci. Total Environ. 2012, 438:42-48.
31. Jing P., Rodgers P.J., Amemiya S. High lipophilicity of perfluoroalkyl carboxylate and sulfonate: implications for their membrane permeability. J. Am. Chem. Soc. 2009, 131:2290-2296.
32. Johansson J.H., Berger U., Vestergren R., Cousins I.T., Bignert A., Glynn A., Darnerud P.O. Temporal trends (1999-2010) of perfluoroalkyl acids in commonly consumed food items. Environ. Pollut. 2014, 188:102-108.
33. Kato K., Wong L.Y., Jia L.T., Kuklenyik Z., Calafat A.M. Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008. Environ. Sci. Technol. 2011, 45:8037-8045.
34. Kato K., Wong L.Y., Basden B.J., Calafat A.M. Effect of temperature and duration of storage on the stability of polyfluoroalkyl chemicals in human serum. Chemosphere 2013, 91:115-117.
35. Kim M., Li L.Y., Grace J.R., Yue C. Selecting reliable physicochemical properties of perfluoroalkyl and polyfluoroalkyl substances (PFASs) based on molecular descriptors. Environ. Pollut. 2015, 196:462-472.
36. Lindstrom A.B., Strynar M.J., Libelo E.L. Polyfluorinated compounds: past, present, and future. Environ. Sci. Technol. 2011, 45:7954-7961.
37. Liu J., Li J., Liu Y., Chan H.M., Zhao Y., Cai Z., Wu Y. Comparison on gestation and lactation exposure of perfluorinated compounds for newborns. Environ. Int. 2011, 37:1206-1212.
38. Magnus P., Irgens L.M., Haug K., Nystad W., Skjaerven R., Stoltenberg C. Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). Int. J. Epidemiol. 2006, 35:1146-1150.
39. Mondal D., Weldon R.H., Armstrong B.G., Gibson L.J., Lopez-Espinosa M.J., Shin H.M., Fletcher T. Breastfeeding: a potential excretion route for mothers and implications for infant exposure to perfluoroalkyl acids. Environ. Health Perspect. 2014, 122:187-192.
40. Morken N.H., Travlos G.S., Wilson R.E., Eggesbo M., Longnecker M.P. Maternal glomerular filtration rate in pregnancy and fetal size. PloS One 2014, 9:e101897.
41. Nilsen R.M., Vollset S.E., Gjessing H.K., Skjaerven R., Melve K.K., Schreuder P., Alsaker E.R., Haug K., Daltveit A.K., Magnus P. Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr. Perinat. Epidemiol. 2009, 23:597-608.
42. Nost T.H., Vestergren R., Berg V., Nieboer E., Odland J.O., Sandanger T.M. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort. Environ. Int. 2014, 67:43-53.
43. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., Zobel L.R. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 2007, 115:1298-1305.
44. Raleigh K.K., Alexander B.H., Olsen G.W., Ramachandran G., Morey S.Z., Church T.R., Logan P.W., Scott L.L., Allen E.M. Mortality and cancer incidence in ammonium perfluorooctanoate production workers. Occup. Environ. Med. 2014, 71:500-506.
45. Ronningen K.S., Paltiel L., Meltzer H.M., Nordhagen R., Lie K.K., Hovengen R., Haugen M., Nystad W., Magnus P., Hoppin J.A. The biobank of the Norwegian Mother and Child Cohort Study: a resource for the next 100 years. Eur. J. Epidemiol. 2006, 21:619-625.
46. Scheringer M., Trier X., Cousins I.T., de Voogt P., Fletcher T., Wang Z., Webster T.F. Helsingor statement on poly- and perfluorinated alkyl substances (PFASs). Chemosphere 2014, 114:337-339.
47. Starling A.P., Engel S.M., Richardson D.B., Baird D.D., Haug L.S., Stuebe A.M., Klungsoyr K., Harmon Q., Becher G., Thomsen C., Sabaredzovic A., Eggesbo M., Hoppin J.A., Travlos G.S., Wilson R.E., Trogstad L.I., Magnus P., Longnecker M.P. Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian mother and child cohort study. Am. J. Epidemiol. 2014.
48. Starling A.P., Engel S.M., Whitworth K.W., Richardson D.B., Stuebe A.M., Daniels J.L., Haug L.S., Eggesbo M., Becher G., Sabaredzovic A., Thomsen C., Wilson R.E., Travlos G.S., Hoppin J.A., Baird D.D., Longnecker M.P. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study. Environ. Int. 2014, 62:104-112.
49. Steenland K., Zhao L., Winquist A., Parks C. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley. Environ. Health Perspect. 2013, 121:900-905.
50. Thomsen C., Haug L.S., Stigum H., Froshaug M., Broadwell S.L., Becher G. Changes in concentrations of perfluorinated compounds, polybrominated diphenyl ethers, and polychlorinated biphenyls in Norwegian breast-milk during twelve months of lactation. Environ. Sci. Technol. 2010, 44:9550-9556.
51. Uhl S.A., James-Todd T., Bell M.L. Association of osteoarthritis with perfluorooctanoate and perfluorooctane sulfonate in NHANES 2003-2008. Environ. Health Perspect. 2013, 121:447-452. 452e441-443.
52. Vestergren R., Cousins I.T. Tracking the pathways of human exposure to perfluorocarboxylates. Environ. Sci. Technol. 2009, 43:5565-5575.
53. Wang Z., Cousins I.T., Scheringer M., Buck R.C., Hungerbuhler K. Global emission inventories for C4-C14 perfluoroalkyl carboxylic acid (PFCA) homologues from 1951 to 2030, Part I: production and emissions from quantifiable sources. Environ. Int. 2014, 70:62-75.
54. White E., Armstrong B., Saracci R. Exposure measurement error and its effects. In:Principles of Exposure Measurement in Epidemiology Collecting, Evaluating, and Improving Measures of Disease Risk Factors 2008, 76-78. Oxford University Press, p. 103. 2nd ed.
55. Whitworth K.W., Haug L.S., Baird D.D., Becher G., Hoppin J.A., Skjaerven R., Thomsen C., Eggesbo M., Travlos G., Wilson R., Longnecker M.P. Perfluorinated compounds and subfecundity in pregnant women. Epidemiology 2012, 23:257-263.
56. Winquist A., Steenland K. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts. Epidemiology 2014, 25:255-264.
57. Wong F., MacLeod M., Mueller J.F., Cousins I.T. Enhanced elimination of perfluorooctane sulfonic acid by menstruating women: evidence from population-based pharmacokinetic modeling. Environ. Sci. Technol. 2014, 48:8807-8814.
58. Woodruff T.J., Zota A.R., Schwartz J.M. Environmental chemicals in pregnant women in the United States: NHANES 2003-2004. Environ. Health Perspect. 2011, 119:878-885.
59. Zhang Y., Beesoon S., Zhu L., Martin J.W. Biomonitoring of perfluoroalkyl acids in human urine and estimates of biological half-life. Environ. Sci. Technol. 2013, 47:10619-10627.